Robin Boineau

Also affiliated with National Center for Complementary and Integrative Health

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT”.

Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.05.061

N/A

3.9DataRank · unranked

88 citations

Brian Olshansky, Daniel B. Mark, Jill Anderson, George Johnson, Anne S. Hellkamp +9 more

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

New England Journal of Medicine(2005)10.1056/nejmoa043399

N/A

1.3DataRank · unranked

6505 citations

Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, Douglas L. Packer, Robin Boineau +17 more

Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)

American Heart Journal(2024)10.1016/j.ahj.2024.04.005

N/A

0.413DataRank · unranked

6 citations

Regina M. Santella, Bonnie R. Joubert, Zhen Huang, Yuliya Lokhnygina, Francisco Ujueta +14 more

The trial to assess chelation therapy 2 (TACT2): Rationale and design

American Heart Journal(2022)10.1016/j.ahj.2022.05.013

N/A

0DataRank · unranked

26 citations

Kevin J. Anstrom, Ana Navas‐Acién, Robin Boineau, Hwasoon Kim, Yves Rosenberg +16 more